Aquestive Therapeutics
AQST
3.46
-0.25
-6.61%
Aquestive Therapeutics
US · AQST
#3650 by market cap
Listed 2018
3.46
-0.25
-6.61%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
D+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 4 analysts
Buy
Avg price target 9.25 +167.3%
Price target rangecurrent 3.46
Low6.00
Avg9.25
High11.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-09 | H.C. Wainwright | -- | Buy | 10.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 11.00 |
| 2026-10-16 | H.C. Wainwright | -- | Buy | 10.00 |
| 2026-10-15 | H.C. Wainwright | -- | Buy | 10.00 |
| 2026-09-21 | H.C. Wainwright | -- | Buy | 10.00 |
| 2026-09-17 | LifeSci Capital | -- | Buy | 10.00 |
| 2026-09-17 | Lake Street | -- | Buy | 6.00 |
| 2026-08-24 | H.C. Wainwright | -- | Buy | 10.00 |
| 2026-08-13 | LifeSci Capital | -- | Buy | 10.00 |
| 2026-08-10 | LifeSci Capital | -- | Buy | 10.00 |
| 2026-08-10 | Lake Street | -- | Buy | 6.00 |
| 2026-06-25 | Cantor Fitzgerald | -- | Buy | 11.00 |
| 2026-06-25 | Chardan Capital | -- | Buy | 8.00 |
| 2026-06-25 | LifeSci Capital | -- | Buy | 9.00 |
| 2026-05-15 | LifeSci Capital | -- | Buy | 9.00 |
| 2026-05-15 | Piper Sandler | -- | Buy | 8.00 |
| 2026-05-15 | Leerink Partners | -- | Buy | 9.00 |
| 2026-05-15 | Lake Street | -- | Buy | 6.00 |
| 2026-05-15 | Oppenheimer | -- | Buy | 8.00 |
| 2026-05-14 | A. G. P. | -- | Buy | 9.00 |
| 2026-04-24 | Oppenheimer | -- | Buy | 8.00 |
| 2026-03-30 | LifeSci Capital | -- | Buy | 9.00 |
| 2026-03-30 | Lake Street | -- | Buy | 6.00 |
| 2026-03-09 | H.C. Wainwright | -- | Buy | 10.00 |
| 2026-03-09 | Oppenheimer | -- | Buy | 8.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | After close | ±14.82% | -2.06% (in line) |
| 2026/Q2 | 2026-08-11 | After close | ±14.74% | -4.08% (in line) |
| 2026/Q1 | 2026-05-13 | After close | ±9.08% | +14.53% (beat) |
| 2025/Q4 | 2026-03-04 | After close | ±16.59% | -2.52% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±15.71% | +2.17% (in line) |
| 2025/Q2 | 2025-08-11 | After close | ±34.59% | -2.07% (in line) |
| 2025/Q1 | 2025-05-12 | After close | ±18.60% | -19.65% (beat) |
| 2024/Q4 | 2025-03-05 | After close | ±24.37% | -7.53% (in line) |
| 2024/Q3 | 2024-11-04 | After close | ±23.30% | -7.67% (in line) |
| 2024/Q2 | 2024-08-06 | After close | ±17.32% | +0.88% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±20.33% | -8.73% (in line) |
| 2023/Q4 | 2024-03-05 | -- | ±50.00% | +20.05% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Aquestive Therapeutics discussion 0 comments